Yes, it does.
Both are inflammatory diseases, causing scarring and once-thought-to-be-inevitable decline in renal function.
It boldens my resolve and excitement for next month.
No doubt, we’ll have profit-takers today. There’s a lot who have been here a long time, but DM is only a month away...
That could well be the goose that lays the golden egg.
Ann: Positive Top-Line Results in FSGS Phase 2a Clinical Study, page-40
-
- There are more pages in this discussion • 247 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
48.0¢ |
Change
-0.010(2.04%) |
Mkt cap ! $266.8M | |||
| Open | High | Low | Value | Volume |
| 49.5¢ | 49.5¢ | 46.5¢ | $1.960M | 4.105M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 70031 | 47.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 48.5¢ | 55820 | 4 |
View Market Depth
| Last trade - 13.37pm 15/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |